Breast cancer PET/CT imaging with a new tracer
Part of Cancer, Skin clinical trials.
This trial tests a new imaging agent (68Ga-pAKTi) that may help doctors see breast cancer cells with a PET/CT scan. It is for people with a specific genetic change in their tumor, and who have not yet had surgery to remove the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have breast cancer, or imaging tests strongly suggest it.
- You have not had surgery to remove the tumor.
- You have had a special test that found a change in your tumor's PIK3CA gene, PTEN gene, or a related pathway (PI3K-AKT-mTOR).
- You are able to lie still for about 30 minutes during a PET/CT scan.
- You agree to use birth control for at least 28 days after the scan (if you or your partner could become pregnant).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new imaging agent that lights up certain proteins on solid tumors during a PET scan. It may help doctors better see tumors and guide treatment decisions.
This trial uses a special PET/CT scan that targets a protein on some cancer cells to help detect and evaluate malignant tumors. It may help doctors better map tumors before any cancer treatment starts.
This study uses a new imaging agent called [68Ga]-FAPI-JNU to take detailed pictures of tumors with a PET/CT scan. It aims to see how well this tracer works in people with various types of cancer.
This trial uses a special PET/CT scan to find breast cancer cells that have a certain marker (CD73). It may help doctors see the cancer more clearly before you start other treatments.
This study tests a new imaging agent (18F-FAPI-04) for PET scans to see if it can better detect breast cancer or its spread. It may help doctors find tumors more clearly.
This trial uses a special PET scan (68Ga-FAPi-46) to see how breast cancer interacts with nearby cells. It may help doctors understand your tumor better and guide treatment decisions, especially if you are planning surgery or chemotherapy before surgery.
Hear when a new PET/CT trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.